Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06728293 · ClinicalTrials.gov registry record · NA
Effect of the HCC Liver-Link Intervention
A NA study of HCC and Racial Disparities, sponsored by Indiana University.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 2
- Study locations
NCT06728293: Recruiting NA study of HCC and Racial Disparities, sponsored by Indiana University.
NCT06728293 is a NA study of HCC and Racial Disparities that is actively recruiting participants, run by Indiana University. The registered enrollment target is 40 participants, below the 199-participant average among 13 other HCC trials with a reported enrollment target (80% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06728293, a NA study of HCC and Racial Disparities, is actively recruiting participants, sponsored by Indiana University.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study is a pilot, multi-center randomized controlled trial testing the HCC Liver-Link intervention, a culturally tailored, multi-level program designed to reduce racial disparities in hepatocellular carcinoma (HCC) care. The intervention combines: (1) patient education to improve HCC-related disease and treatment knowledge, (2) social needs and substance use screening with referral to social work and community resources, and (3) facilitated access to subspecialty cancer care through a multidisciplinary HCC tumor board. A total of 40 Black patients with Barcelona Clinic Liver Cancer (BCLC) stage 0, A, or downstaged B disease will be randomized to receive either the HCC Liver-Link intervention or usual care and followed for 6 months or until liver transplant waitlisting. Primary outcomes are time to receipt of curative therapies (liver transplantation or resection) and change in HCC-related knowledge. Findings will inform development of larger interventions to eliminate racial disparities in HCC outcomes.
Primary Outcome
Days from study enrollment to liver transplant waitlisting, assessed using OTTR.
Conditions Studied
Interventions
- OTHER Liver Link
Study Locations (2)
Indiana
- Indiana University School of Medicine - Indianapolis
Maryland
- Johns Hopkins University - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-06-10 |
| Est. Completion | 2026-06 |
| Phase | NA |
What NCT06728293 shows while recruiting
NCT06728293 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 199-participant average among 13 other HCC trials with a reported enrollment target (80% lower).
The record links to 2 conditions, with HCC appearing as the primary indexed condition, and to 1 intervention - of which Liver Link is the first listed.
NCT06728293 reports a single indexed study location in Indiana, Maryland.
Frequently Asked Questions
What is clinical trial NCT06728293 about?
NCT06728293 is a clinical study titled "Effect of the HCC Liver-Link Intervention". This study is a pilot, multi-center randomized controlled trial testing the HCC Liver-Link intervention, a culturally tailored, multi-level program designed to reduce racial disparities in hepatocellular carcinoma (HCC) care. The intervention combines: (1) patient education to improve HCC-related di...
What is the current status of trial NCT06728293?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-06-10. Estimated completion is 2026-06.
What conditions does trial NCT06728293 study?
This clinical trial studies the following conditions: HCC, Racial Disparities.
What interventions are being tested in trial NCT06728293?
The interventions under investigation include: Liver Link (OTHER).
Who is sponsoring clinical trial NCT06728293?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06728293 being conducted?
This trial has 2 study locations across Indiana, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HCC
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06728293's enrollment target sits among peer trials
40 9th of 13 higher than 5 of 13 other HCC trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HCC trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CEUS vs. AMRI for HCC Detection in Patients With Indeterminate Liver Nodules
RECRUITING · NA
-
Evaluation of Liver Cancer With Magnetic Resonance Imaging (MRI)
COMPLETED · NA
-
Multi-analyte Blood Test Clinical Trial
RECRUITING
-
HOPE Against Cancer Recurrence in HCC
RECRUITING · Phase 4
-
REGULUS: MRI-guided Adaptive SABR for Liver Cancers
RECRUITING · Phase 2
-
Y-90 Treatment Response Using Transarterial Radioembolization
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI